BMJ Open publishes all reviews undertaken for accepted manuscripts. Reviewers are asked to complete a checklist review form (see an example) and are provided with free text boxes to elaborate on their assessment. These free text comments are reproduced below. Some articles will have been accepted based in part or entirely on reviews undertaken for other BMJ Group journals. These will be reproduced where possible.
The Introduction would be helped by incorporating greater structure and purpose to the paragraphs. Many statistics are provided that are not directly relevant to the subject of the paper. For example region-specific estimates for OSCC are provided, however no mention of these regions is made in the meta-analysis, nor any region-specific strata generated.
The rationale for the scoring instrument is unclear, and little information provided as to its reproducibility. How subjective are the actual values, and to what extent could this subjectiveness influence the final results as shown in Table 3 ? Has the scale been validated across different research teams?
In the "Cumulative meta-analysis", it is stated that "All studies demonstrated a positive HPV-OSCC association." More careful wording should be used here, as on face value this interpretation contradicts what is shown in Figures 2 and 5 , where there are 2 (small) studies that show a non-significant protective effect. Did the authors consider a cumulative analysis based on study size?
In the Discussion, it is stated "… no single domain of quality assessed in each study influenced the estimates ORs by metaregression analysis." How does this match with the result in Table 3 , where the co-efficient for analysis was significant?
While the authors mention "by the analyses of all subcategories" (Discussion), the subcategory-specific analyses are rather limited. Is it possible to separate the studies by other categories, for example by geographical area?
Minor: There are a number of instances of incorrect English grammar. For example the opening sentence of the introduction "HPV is the one of the most significant….". Further editing is required.
The abbreviation "HPV" should be defined in the abstract and introduction.
Comment: The authors refer to a recently accepted publication (PLoS One, 2013 ) that contains a global meta-analysis of the aetiological role of HPV in OSCC. It is unclear to what extent this current meta-analysis for China reflects simply a subset of the global analysis. If this is the case, then additional acknowledgement of this should be included in the Introduction, and greater comparison made with the findings of the global study. In addition, there should be a strong justification why it could be suspected that the association in China was any different to the global association. Response: We would like to clarify that the Chinese meta-analysis is not a sub-set of the global meta-analysis. The latter was a meta-analysis of all papers published in the English language, which identified only 6 studies conducted in China. The Chinese meta-analysis submitted to BMJ Open is a meta-analysis of all studies done in China and published in both the English language and Chinese. This entailed searching the Chinese literature and identifying all studies published in Chinese language, a process which identified an additional 9 studies published in Chinese language (see p.5, lines, 32-35 and p.10, lines, 4-9). Further, in the global meta-analysis for about half (9 out of 21) studies the ORs could not be calculated from the original studies because of zero cell values. In the China study there were only 2 studies with this issue and the effect is stronger compared to the global analysis.
Comment: The Introduction would be helped by incorporating greater structure and purpose to the paragraphs. Many statistics are provided that are not directly relevant to the subject of the paper. For example region-specific estimates for OSCC are provided, however no mention of these regions is made in the meta-analysis, nor any region-specific strata generated. Response: The introduction has been significantly revised to improve clarity and flow of logic. We did a region specific analysis in response to this comment, and tested various regions (northwest, southern, northern, eastern), but did not find that region predicted any significant difference in HPV risk (p. 9, lines, 2&3). This is probably because the published studies were mostly conducted in high-incidence regions. The geographic regions represented were diverse, so that any one region had a maximum of 3-4 studies. An example of one analysis is included here to illustrate (north-west region vs others, as north-west is traditionally thought of as high OSCC risk). We have added in the methods, results and discussion that we have examined region, but that wasn't significant (p.7, lines, 24&25 and p.10, lines, 19&20) . Please see uploaded figure for region-specific analysis (for review only).
Comment: The rationale for the scoring instrument is unclear, and little information provided as to its reproducibility. How subjective are the actual values, and to what extent could this subjectiveness influence the final results as shown in Table 3 ? Has the scale been validated across different research teams? Response: The same quality scoring instrument was used both in this paper and previous meta-analysis (Plos One, 2013; ref# 24) . This instrument was validated and it demonstrated a very good reliability with an intra-class correlation of 87% for the total quality domain. This information has been added to the methods section of the manuscript (p. 7, lines, 5-7).
Comment:In the "Cumulative meta-analysis", it is stated that "All studies demonstrated a positive HPV-OSCC association." More careful wording should be used here, as on face value this interpretation contradicts what is shown in Figures 2 and 5 , where there are 2 (small) studies that show a non-significant protective effect. Did the authors consider a cumulative analysis based on study size? Response: We have changed the statement it now reads "At the time of publication of all the studies the cumulative evidence demonstrated a positive lines, [26] [27] [28] [29] [30] . We conducted a cumulative meta-analysis by study size which also demonstrated a steady effect (OR=3.65) with larger studies. We did not present this result in the manuscript because cumulative analysis of the two types showed similar result and the analysis by time is more commonly reported.
Comment: In the Discussion, it is stated "… no single domain of quality assessed in each study influenced the estimates ORs by meta-regression analysis." How does this match with the result in Table 3 , where the co-efficient for analysis was significant? Response: We apologise, there was an error in the data entered in Table 3 . We corrected the data now -all the coefficients are highly non-significant. Comment: While the authors mention "by the analyses of all subcategories" (Discussion), the subcategory-specific analyses are rather limited. Is it possible to separate the studies by other categories, for example by geographical area? Response: See response above and example of regional analysis. We examined other possible categories for analysis and did not find any which add to the present analysis.
Minor:
Comment: There are a number of instances of incorrect English grammar. For example the opening sentence of the introduction "HPV is the one of the most significant….". Further editing is required. The abbreviation "HPV" should be defined in the abstract and introduction. Response: We have revised the manuscript accordingly. This in an excellent study which has the novelty to focus on the field of infection and cancer in esophageal cancer.
